Cited by 277HIV-related health complications and treatmentsHIV Research and TreatmentInfectious Diseases and Tuberculosis

Ageing and inflammation in patients with HIV infection

Open access
Nasi, M, De Biasi, S, Gibellini, L, Bianchini, E, Pecorini, S, Bacca, V, Guaraldi, G, Mussini, C +2 more·2016·Clinical and Experimental Immunology

Abstract

Summary: Nowadays, HIV+ patients have an expected lifespan that is only slightly shorter than healthy individuals. For this reason, along with the fact that infection can be acquired at a relatively advanced age, the effects of ageing on HIV+ people have begun to be evident. Successful anti-viral treatment is, on one hand, responsible for the development of side effects related to drug toxicity; on the other hand, it is not able to inhibit the onset of several complications caused by persistent immune activation and chronic inflammation. Therefore, patients with a relatively advanced age, i.e. aged more than 50 years, can experience pathologies that affect much older citizens. HIV+ individuals with non-AIDS-related complications can thus come to the attention of clinicians because of the presence of neurocognitive disorders, cardiovascular diseases, metabolic syndrome, bone abnormalities and non-HIV-associated cancers. Chronic inflammation and immune activation, observed typically in elderly people and defined as ‘inflammaging’, can be present in HIV+ patients who experience a type of premature ageing, which affects the quality of life significantly. This relatively new condition is extremely complex, and important factors have been identified as well as the traditional behavioural risk factors, e.g. the toxicity of anti-retroviral treatments and the above-mentioned chronic inflammation leading to a functional decline and a vulnerability to injury or pathologies. Here, we discuss the role of inflammation and immune activation on the most important non-AIDS-related complications of chronic HIV infection, and the contribution of aging per se to this scenario.

Integrity signals

Registry

Crossref · 10.1111/cei.12814

Cites

124 of 124 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • HAART does not protect patients from persistent immune activation, chronic inflammation, and excess risk of developing CVD and frailty.

    “However, this therapy does not protect patients from the persistent immune activation, chronic inflammation, and excess risk of developing CVD and frailty131–135.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Nasi, M., De Biasi, S., Gibellini, L., Bianchini, E., Pecorini, S., Bacca, V, Guaraldi, G., Mussini, C., Pinti, M., & Cossarizza, A.
Affiliations
  • Department of Surgery, Medicine, Dentistry and Morphological Sciences, Modena, Italy
  • University of Modena and Reggio Emilia (IT)
  • Azienda Ospedaliero-Universitaria di Modena (IT)
Venue
Clinical and Experimental Immunology
Published
2016-08-09
Volume
187
Issue
1
Pages
44-52
ISSN
  • 0009-9104 (ISSN-L)
  • 1365-2249
OpenAlex
W2404185225
Cited by
277
References
124
Citations by year
2026: 22 · 2025: 31 · 2024: 29 · 2023: 24 · 2022: 27 · 2021: 43 · 2020: 27 · 2019: 34 · 2018: 20 · 2017: 17 · 2016: 3
FWCI
5.65
Type
journal article
Language
en
Open access
Locations
  • Clinical & Experimental Immunology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Emergency Medicine › HIV-related health complications and treatments
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Health Sciences › Medicine › Surgery › Infectious Diseases and Tuberculosis
Keywords
HIV infection, aging, chronic inflammation, immune activation, inflammaging, premature aging, antiretroviral therapy adverse effects, neurocognitive disorders, cardiovascular disease, metabolic syndrome, bone abnormalities, older adults
MeSH terms
Age Factors, Aged, Aging, Animals, Cardiovascular Diseases, Chronic Disease, Humans, Inflammation, Middle Aged, Neoplasms, HIV Infections, Neurocognitive Disorders, Metabolic Syndrome, Anti-Retroviral Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review